Cereno Scientific reports insider share purchases
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announces that insider share purchases have been completed. Sten R. Sörensen, CEO of Cereno Scientific, has purchased a total of 7,000 B-shares on December 2, 2024 for a total value of approximately SEK 40 thousand. The insider purchases have been made on Nasdaq First North Growth Market.Sten R. Sörensen, CEO, has purchased a total of 7,000 B-shares in the company. The purchase was made on December 2,2024,